TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells
Authors
Keywords
-
Journal
Science Immunology
Volume 7, Issue 74, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-08-20
DOI
10.1126/sciimmunol.abn6563
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Key chemokines direct migration of immune cells in solid tumors
- (2021) Karan Kohli et al. CANCER GENE THERAPY
- Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure
- (2021) Mallory Paynich Murray et al. Nature Communications
- Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming
- (2021) Federico Simonetta et al. CLINICAL CANCER RESEARCH
- Tumor-associated macrophages
- (2020) Luca Cassetta et al. CURRENT BIOLOGY
- Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
- (2020) Andras Heczey et al. NATURE MEDICINE
- TCR Gene Therapy: Challenges, Opportunities, and Future Directions
- (2020) Hans J. Stauss et al. Cells
- NKT cells co-expressing a GD2-specific chimeric antigen receptor and IL-15 show enhanced in vivo persistence and antitumor activity against neuroblastoma
- (2019) Xin Xu et al. CLINICAL CANCER RESEARCH
- A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor
- (2019) Elisa Landoni et al. Cancer Immunology Research
- Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
- (2019) Iñaki Etxeberria et al. CANCER CELL
- Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells
- (2018) Kavitha Gowrishankar et al. MAMMALIAN GENOME
- EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens
- (2018) Mario Leonardo Squadrito et al. NATURE METHODS
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
- (2018) Mirjana Efremova et al. Nature Communications
- Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression
- (2018) Filippo Cortesi et al. Cell Reports
- Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting
- (2018) Antonia Rotolo et al. CANCER CELL
- Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice
- (2017) Naveena B. Janakiram et al. IMMUNOLOGY
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- flowAI: automatic and interactive anomaly discerning tools for flow cytometry data
- (2016) Gianni Monaco et al. BIOINFORMATICS
- An injectable nanoparticle generator enhances delivery of cancer therapeutics
- (2016) Rong Xu et al. NATURE BIOTECHNOLOGY
- Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavity
- (2015) Elizabeth S. DeLyria et al. CARBOHYDRATE RESEARCH
- Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
- (2015) Jacob H. Levine et al. CELL
- Multistage vector (MSV) therapeutics
- (2015) Joy Wolfram et al. JOURNAL OF CONTROLLED RELEASE
- Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
- (2015) Matthias Obenaus et al. NATURE BIOTECHNOLOGY
- Porous Silicon Microparticle Potentiates Anti-Tumor Immunity by Enhancing Cross-Presentation and Inducing Type I Interferon Response
- (2015) Xiaojun Xia et al. Cell Reports
- Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
- (2015) Yusuf Dölen et al. OncoImmunology
- Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
- (2014) A. Heczey et al. BLOOD
- Optimization of Natural Killer T Cell–Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector Vaccines
- (2014) C. Faveeuw et al. CANCER RESEARCH
- KLRG+ invariant natural killer T cells are long-lived effectors
- (2014) K. Shimizu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional Education of Invariant NKT Cells by Dendritic Cell Tuning of SHP-1
- (2013) A. Napolitano et al. JOURNAL OF IMMUNOLOGY
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
- (2012) Daofeng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
- (2012) Elena Provasi et al. NATURE MEDICINE
- CD3 limits the efficacy of TCR gene therapy in vivo
- (2011) M. Ahmadi et al. BLOOD
- Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of -GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
- (2011) A. J. Nicol et al. CLINICAL CANCER RESEARCH
- The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment
- (2011) Jung-Mi Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles
- (2011) Elodie Macho Fernandez et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
- (2011) Steven A. Rosenberg Nature Reviews Clinical Oncology
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
- (2010) Leonid S. Metelitsa CLINICAL IMMUNOLOGY
- Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
- (2010) Carmela De Santo et al. NATURE IMMUNOLOGY
- Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
- (2010) Gavin M Bendle et al. NATURE MEDICINE
- Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
- (2010) Michael Nowak et al. PLoS One
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
- (2009) Liping Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
- (2009) H.-J. Ko et al. JOURNAL OF IMMUNOLOGY
- Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
- (2008) Carmela De Santo et al. JOURNAL OF CLINICAL INVESTIGATION
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started